|
1
|
Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis.
|
Blood
|
2010
|
1.91
|
|
2
|
A prospective and comparative cohort study on efficacy and drug resistance during long-term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis.
|
J Gastroenterol Hepatol
|
2007
|
1.54
|
|
3
|
Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid.
|
J Gastroenterol Hepatol
|
2011
|
1.49
|
|
4
|
Serum levels of platelet-derived growth factor-BB and vascular endothelial growth factor as prognostic factors for patients with fulminant hepatic failure.
|
J Gastroenterol Hepatol
|
2011
|
1.45
|
|
5
|
Twist expression promotes migration and invasion in hepatocellular carcinoma.
|
BMC Cancer
|
2009
|
1.44
|
|
6
|
Predicting the treatment effect of sorafenib using serum angiogenesis markers in patients with hepatocellular carcinoma.
|
J Gastroenterol Hepatol
|
2011
|
1.10
|
|
7
|
Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice.
|
Hepatology
|
2012
|
1.01
|
|
8
|
Risk factors for acute renal injury in living donor liver transplantation: evaluation of the RIFLE criteria.
|
Transpl Int
|
2013
|
0.98
|
|
9
|
Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma.
|
J Biol Chem
|
2004
|
0.98
|
|
10
|
Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration.
|
J Biol Chem
|
2007
|
0.96
|
|
11
|
Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
|
Int J Cancer
|
2012
|
0.93
|
|
12
|
Long-term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine.
|
Hepatol Res
|
2011
|
0.93
|
|
13
|
Lamivudine treatment improves the prognosis of fulminant hepatitis B.
|
Intern Med
|
2008
|
0.93
|
|
14
|
In vitro analysis of gastric phytobezoar dissolubility by coca-cola, coca-cola zero, cellulase, and papain.
|
J Clin Gastroenterol
|
2014
|
0.92
|
|
15
|
The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis.
|
J Gastroenterol
|
2012
|
0.91
|
|
16
|
Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinoma.
|
J Gastroenterol
|
2011
|
0.90
|
|
17
|
Serum glycan markers for evaluation of disease activity and prediction of clinical course in patients with ulcerative colitis.
|
PLoS One
|
2013
|
0.89
|
|
18
|
Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein.
|
J Gastroenterol Hepatol
|
2011
|
0.89
|
|
19
|
Contrast-enhanced ultrasonography depicts small tumor vessels for the evaluation of pancreatic tumors.
|
Eur J Radiol
|
2006
|
0.88
|
|
20
|
Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer.
|
J Gastroenterol
|
2013
|
0.87
|
|
21
|
Clinical features of antinuclear antibodies-negative type 1 autoimmune hepatitis.
|
Hepatol Res
|
2008
|
0.87
|
|
22
|
Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis.
|
Intern Med
|
2007
|
0.87
|
|
23
|
Potential of adenovirus-mediated REIC/Dkk-3 gene therapy for use in the treatment of pancreatic cancer.
|
J Gastroenterol Hepatol
|
2014
|
0.86
|
|
24
|
Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis.
|
BMC Cancer
|
2011
|
0.86
|
|
25
|
Evaluation of the effect of sorafenib using serum NX-des-γ-carboxyprothrombin in patients with hepatocellular carcinoma.
|
Hepatol Res
|
2013
|
0.86
|
|
26
|
Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients.
|
BMC Cancer
|
2011
|
0.86
|
|
27
|
Clinical features of autoimmune hepatitis diagnosed based on simplified criteria of the International Autoimmune Hepatitis Group.
|
Dig Liver Dis
|
2009
|
0.85
|
|
28
|
Amino acid substitutions of hepatitis C virus core protein are not associated with intracellular antiviral response to interferon-α in vitro.
|
Liver Int
|
2010
|
0.85
|
|
29
|
+49A/G polymorphism of cytotoxic T-lymphocyte antigen 4 gene in type 1 autoimmune hepatitis and primary biliary cirrhosis: A meta-analysis.
|
Hepatol Res
|
2011
|
0.85
|
|
30
|
Efficacy of sorafenib beyond first progression in patients with metastatic hepatocellular carcinoma.
|
Hepatol Res
|
2013
|
0.85
|
|
31
|
Long-term monitoring of platelet count, as a non-invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy.
|
J Gastroenterol Hepatol
|
2006
|
0.82
|
|
32
|
Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma.
|
J Gastroenterol Hepatol
|
2012
|
0.82
|
|
33
|
Loss of runt-related transcription factor 3 induces gemcitabine resistance in pancreatic cancer.
|
Mol Oncol
|
2013
|
0.82
|
|
34
|
Clinical utility of serum fucosylated hemopexin in Japanese patients with hepatocellular carcinoma.
|
Hepatol Res
|
2012
|
0.82
|
|
35
|
Feasibility and findings of colonoscopy for living-donor liver transplant candidates.
|
J Clin Gastroenterol
|
2009
|
0.81
|
|
36
|
Predictive impact of polymorphism of PNPLA3 on HCC development after interferon therapy in Japanese patients with chronic hepatitis C.
|
Springerplus
|
2013
|
0.81
|
|
37
|
Early detection and quantification of lamivudine-resistant hepatitis B virus mutants by fluorescent biprobe hybridization assay in lamivudine-treated patients.
|
J Gastroenterol
|
2006
|
0.81
|
|
38
|
Combination of 5-FU and IFNalpha enhances IFN signaling pathway and caspase-8 activity, resulting in marked apoptosis in hepatoma cell lines.
|
Int J Oncol
|
2006
|
0.81
|
|
39
|
Human leukocyte antigen DR status and clinical features in Japanese patients with type 1 autoimmune hepatitis.
|
Hepatol Res
|
2007
|
0.81
|
|
40
|
Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement.
|
World J Gastroenterol
|
2012
|
0.80
|
|
41
|
Efficacy of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis.
|
Hepatol Int
|
2009
|
0.80
|
|
42
|
Efficacy of hepatic arterial infusion chemotherapy in combination with irradiation for advanced hepatocellular carcinoma with portal vein invasion.
|
Hepatol Int
|
2014
|
0.80
|
|
43
|
Low frequency of drug-resistant virus did not affect the therapeutic efficacy in daclatasvir plus asunaprevir therapy in patients with chronic HCV genotype-1 infection.
|
Antivir Ther
|
2015
|
0.80
|
|
44
|
Stage of hepatocellular carcinoma is associated with periodontitis.
|
J Clin Periodontol
|
2011
|
0.80
|
|
45
|
Involvement of platelets in extrahepatic metastasis of hepatocellular carcinoma.
|
Hepatol Res
|
2014
|
0.79
|
|
46
|
Exon 2 deletion splice variant of gamma-glutamyl carboxylase causes des-gamma-carboxy prothrombin production in hepatocellular carcinoma cell lines.
|
Mol Oncol
|
2008
|
0.79
|
|
47
|
Serial changes of serum growth factor levels and liver regeneration after partial hepatectomy in healthy humans.
|
Int J Mol Sci
|
2013
|
0.79
|
|
48
|
Impact of comorbid hepatic steatosis on treatment of chronic hepatitis C in Japanese patients and the relationship with genetic polymorphism of IL28B, PNPLA3 and LDL receptor.
|
Acta Med Okayama
|
2014
|
0.79
|
|
49
|
Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B.
|
Hepatol Int
|
2008
|
0.79
|
|
50
|
A preliminary study for constructing a bioartificial liver device with induced pluripotent stem cell-derived hepatocytes.
|
Biomed Eng Online
|
2012
|
0.78
|
|
51
|
SIRS score reflects clinical features of non-acetaminophen-related acute liver failure with hepatic coma.
|
Intern Med
|
2012
|
0.78
|
|
52
|
Serum levels of soluble adhesion molecules as prognostic factors for acute liver failure.
|
Digestion
|
2012
|
0.78
|
|
53
|
Hepatitis B e antigen predicts delayed reduction of HBV DNA without viral breakthrough with adefovir dipivoxil and lamivudine: a 5-year study of patients with hepatitis B with lamivudine resistance.
|
J Med Virol
|
2012
|
0.78
|
|
54
|
Serum oxidative-anti-oxidative stress balance is dysregulated in patients with hepatitis C virus-related hepatocellular carcinoma.
|
Hepatol Res
|
2013
|
0.78
|
|
55
|
Prognotic impact of serum follistatin in patients with hepatocellular carcinoma.
|
J Gastroenterol Hepatol
|
2013
|
0.78
|
|
56
|
Use of non-invasive serum glycan markers to distinguish non-alcoholic steatohepatitis from simple steatosis.
|
J Gastroenterol Hepatol
|
2015
|
0.77
|
|
57
|
Alteration of N-glycan profiles in patients with chronic hepatitis and hepatocellular carcinoma.
|
Hepatol Res
|
2014
|
0.77
|
|
58
|
Anti-programmed cell death-1 antibody as a new serological marker for type 1 autoimmune hepatitis.
|
J Gastroenterol Hepatol
|
2014
|
0.77
|
|
59
|
Effects of pulsing procedure of interleukin-12 in combination with interleukin-2 on the activation of peripheral blood lymphocytes derived from patients with hepatocellular carcinoma.
|
Acta Med Okayama
|
2003
|
0.77
|
|
60
|
Clinical features of type 1 autoimmune hepatitis in adolescence and early adulthood.
|
Hepatol Res
|
2009
|
0.77
|
|
61
|
Nursing support increases the efficacy of interferon therapy in patients with chronic hepatitis C.
|
Acta Med Okayama
|
2014
|
0.77
|
|
62
|
Local recurrence and complications after percutaneous radiofrequency ablation of hepatocellular carcinoma: a retrospective cohort study focused on tumor location.
|
Acta Med Okayama
|
2015
|
0.77
|
|
63
|
Prognostic value of altered N-glycosylation of circulating glycoproteins in patients with unresectable pancreatic cancer treated with gemcitabine.
|
Pancreas
|
2015
|
0.77
|
|
64
|
Entecavir Reduces Hepatocarcinogenesis in Chronic Hepatitis B Patients.
|
Acta Med Okayama
|
2016
|
0.76
|
|
65
|
Assessment of health-related quality of life and how it predicts the outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C.
|
J Gastroenterol Hepatol
|
2014
|
0.76
|
|
66
|
Long-term observation of osteomalacia caused by adefovir-induced Fanconi's syndrome.
|
Acta Med Okayama
|
2014
|
0.76
|
|
67
|
TLR4, TLR9, and NLRP3 in biliary epithelial cells of primary sclerosing cholangitis: relationship with clinical characteristics.
|
J Gastroenterol Hepatol
|
2015
|
0.76
|
|
68
|
Serum Oxidative/anti-oxidative Stress Balance Is Dysregulated in Potentially Pulmonary Hypertensive Patients with Liver Cirrhosis: A Case Control Study.
|
Intern Med
|
2015
|
0.75
|
|
69
|
Endoscopic therapy for bleeding esophageal varices improves the outcome of Child C cirrhotic patients.
|
J Gastroenterol Hepatol
|
2006
|
0.75
|
|
70
|
Enhancement of Programmed Death Ligand 2 on Hepatitis C Virus Infected Hepatocytes by Calcineurin Inhibitors.
|
Transplantation
|
2015
|
0.75
|
|
71
|
Aberrant Expression of Keratin 7 in Hepatocytes as a Predictive Marker of Rapid Progression to Hepatic Failure in Asymptomatic Primary Biliary Cirrhosis.
|
Acta Med Okayama
|
2015
|
0.75
|
|
72
|
The Serum Oxidative/Anti-oxidative Stress Balance Becomes Dysregulated in Patients with Non-alcoholic Steatohepatitis Associated with Hepatocellular Carcinoma.
|
Intern Med
|
2017
|
0.75
|
|
73
|
Effectiveness of extending treatment duration in therapy with pegylated interferon and ribavirin for genotype 2 hepatitis C virus infection.
|
Acta Med Okayama
|
2015
|
0.75
|
|
74
|
Hepatic angiosarcoma with characteristic laparoscopic findings.
|
Dig Endosc
|
2012
|
0.75
|
|
75
|
Polycythemia Vera Diagnosed after Esophageal Variceal Rupture.
|
Intern Med
|
2015
|
0.75
|
|
76
|
Living Donor Liver Transplantation for Acute Liver Failure : Comparing Guidelines on the Prediction of Liver Transplantation.
|
Acta Med Okayama
|
2017
|
0.75
|
|
77
|
Randomized trial of peginterferon alpha-2b plus low and escalating dose of ribavirin in patients with chronic hepatitis C with high viral load genotype 1.
|
J Med Virol
|
2015
|
0.75
|
|
78
|
Hepatitis C virus-specific T-cell response correlates with hepatitis activity and donor IL28B genotype early after liver transplantation.
|
Acta Med Okayama
|
2014
|
0.75
|
|
79
|
Eradication of hepatitis C virus subgenomic replicon by interferon results in aberrant retinol-related protein expression.
|
Acta Med Okayama
|
2012
|
0.75
|
|
80
|
Fulminant hepatitis: Who survives without liver transplantation?
|
Hepatol Res
|
2011
|
0.75
|
|
81
|
Hepatocellular carcinoma occurring in hepatobiliary fibropolycystic disease.
|
Hepatol Res
|
2011
|
0.75
|
|
82
|
[Correlation between the grade of immune response against hepatitis C virus (HCV) infection and MHC class II polymorphisms].
|
Nihon Rinsho
|
2004
|
0.75
|
|
83
|
Acute hepatitis due to hepatitis E virus genotype 1 as an imported infectious disease in Japan.
|
Intern Med
|
2010
|
0.75
|
|
84
|
A homosexual Japanese man with acute hepatitis due to hepatitis B virus genotype ae, concurrent with amebic colitis.
|
Acta Med Okayama
|
2007
|
0.75
|
|
85
|
Laparoscopic findings of reddish markings predict hepatocellular carcinoma in patients with hepatitis B virus-related liver disease.
|
J Gastroenterol
|
2010
|
0.75
|
|
86
|
[A case of the usage of entecavir to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patient].
|
Gan To Kagaku Ryoho
|
2011
|
0.75
|
|
87
|
A case of unresectable combined hepatocellular cholangiocarcinoma showing favorable response to LFP therapy.
|
Nihon Shokakibyo Gakkai Zasshi
|
2016
|
0.75
|
|
88
|
Prognostic model for hepatocellular carcinoma with time-dependent factors.
|
Acta Med Okayama
|
2011
|
0.75
|
|
89
|
A case of Wilson's disease with characteristic laparoscopic findings.
|
Clin J Gastroenterol
|
2014
|
0.75
|
|
90
|
A case of fulminant liver failure associated with hepatitis C virus.
|
Clin J Gastroenterol
|
2014
|
0.75
|
|
91
|
Prevention of vagotonia and pain during radiofrequency ablation of liver tumors.
|
Hepatol Res
|
2014
|
0.75
|
|
92
|
Prevalence and outcomes of acute hepatitis B in Okayama, Japan, 2006-2010.
|
Acta Med Okayama
|
2014
|
0.75
|